Great Lakes Advisors LLC trimmed its stake in shares of Balchem Co. (NASDAQ:BCPC – Free Report) by 4.5% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 30,788 shares of the basic materials company’s stock after selling 1,436 shares during the quarter. Great Lakes Advisors LLC owned 0.10% of Balchem worth $3,894,000 at the end of the most recent quarter.
Other large investors also recently bought and sold shares of the company. Quantbot Technologies LP purchased a new stake in shares of Balchem during the first quarter worth approximately $34,000. Benjamin Edwards Inc. grew its holdings in Balchem by 158.3% during the 1st quarter. Benjamin Edwards Inc. now owns 421 shares of the basic materials company’s stock worth $53,000 after acquiring an additional 258 shares in the last quarter. Gyon Technologies Capital Management LP purchased a new stake in shares of Balchem in the 4th quarter valued at approximately $56,000. Belpointe Asset Management LLC acquired a new stake in shares of Balchem in the 4th quarter valued at $66,000. Finally, Point72 Hong Kong Ltd purchased a new stake in shares of Balchem during the 1st quarter worth $67,000. Hedge funds and other institutional investors own 87.51% of the company’s stock.
Wall Street Analysts Forecast Growth
Several equities analysts recently commented on the company. HC Wainwright increased their target price on Balchem from $150.00 to $165.00 and gave the company a “buy” rating in a report on Monday, July 31st. StockNews.com began coverage on Balchem in a research report on Thursday. They set a “hold” rating on the stock.
Balchem Stock Down 0.1 %
Shares of NASDAQ:BCPC opened at $136.56 on Friday. The company has a current ratio of 2.94, a quick ratio of 1.85 and a debt-to-equity ratio of 0.42. The firm has a 50 day simple moving average of $133.37 and a 200-day simple moving average of $130.42. The company has a market capitalization of $4.40 billion, a PE ratio of 44.48 and a beta of 0.71. Balchem Co. has a twelve month low of $116.68 and a twelve month high of $143.88.
Balchem (NASDAQ:BCPC – Get Free Report) last released its quarterly earnings data on Friday, July 28th. The basic materials company reported $0.93 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.80 by $0.13. Balchem had a net margin of 10.58% and a return on equity of 10.43%. The company had revenue of $231.25 million during the quarter, compared to the consensus estimate of $241.00 million. On average, equities analysts predict that Balchem Co. will post 3.5 EPS for the current fiscal year.
Balchem Company Profile
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.
See Also
- Five stocks we like better than Balchem
- Utilities Stocks Explained – How and Why to Invest in Utilities
- MarketBeat Week in Review – 8/14 – 8/18
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- 8 Best Artificial Intelligence Stocks Under $10
- Upcoming IPO Stock Lockup Period, Explained
- What Ross Stores Earnings Say About The Saver Shopping Economy
Receive News & Ratings for Balchem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Balchem and related companies with MarketBeat.com's FREE daily email newsletter.
